Investor Relations

Investor Home

Investor Home

Corporate Profile

MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which MediciNova believes has a well-characterized and differentiated therapeutic profile, attractive commercial potential and patent assets having claims of commercially adequate... More

Stock Quote

()
Exchange (USD)
Price
Change (%)  (%)
Volume
Data as of

Minimum 15 minutes delayed. Source: LSEG

More
Upcoming Events
There are currently no events scheduled.

Receive E-mail Alerts

You may automatically receive Medicinova Inc financial information by email. For email notification, please click here.